Edition:
India

Mediclinic International PLC (MDCM.L)

MDCM.L on London Stock Exchange

293.40GBp
26 Jun 2019
Change (% chg)

-4.00 (-1.34%)
Prev Close
297.40
Open
296.00
Day's High
296.80
Day's Low
292.30
Volume
778,745
Avg. Vol
1,217,501
52-wk High
549.40
52-wk Low
288.30

Latest Key Developments (Source: Significant Developments)

Mediclinic's Swiss Hospital Operators Have Been Affected By Outpatient Tariff Reductions
Thursday, 23 May 2019 

May 23 (Reuters) - Mediclinic International PLC ::MEDICLINIC INTNL PLC - FINAL RESULTS.MEDICLINIC INTERNATIONAL PLC - GROUP ADJUSTED FULL-YEAR FINANCIAL RESULTS IN LINE WITH MARKET EXPECTATIONS.MEDICLINIC INTERNATIONAL PLC - PROPOSED FINAL DIVIDEND MAINTAINED AT 4.70 PENCE PER SHARE.MEDICLINIC INTERNATIONAL PLC - CURRENT TRADING IN LINE WITH EXPECTATIONS; GUIDANCE REMAINS UNCHANGED.MEDICLINIC INTERNATIONAL PLC - FY REVENUE UP 2% TO GBP2 932M; UP 4% IN CONSTANT CURRENCY TERMS.MEDICLINIC INTERNATIONAL PLC - FY ADJUSTED EBITDA OF GBP493M DOWN 4%; DOWN 2% IN CONSTANT CURRENCY TERMS.MEDICLINIC INTERNATIONAL PLC - FY ADJUSTED OPERATING PROFIT OF GBP330M DOWN 11%.MEDICLINIC - OVER LAST 18 MONTHS, SWISS HOSPITAL OPERATORS AFFECTED BY IMPLEMENTED REGULATORY CHANGES RELATED TO OUTPATIENT TARIFF REDUCTIONS.MEDICLINIC INTERNATIONAL PLC - TOOK ACTIONS TO IMPROVE HIRSLANDEN'S PERFORMANCE.MEDICLINIC INTERNATIONAL PLC - HIRSLANDEN DELIVERING A 16% EBITDA MARGIN FOR FULL YEAR, IN LINE WITH GUIDANCE..MEDICLINIC INTERNATIONAL PLC - DISAPPOINTING PERFORMANCE AT HIRSLANDEN WHERE CHANGES HAVE IMPACTED TARIFF ENVIRONMENT AND INPATIENT INSURANCE MIX.  Full Article

Mediclinic International Says 2019 Results Were In Line With Market Expectations
Wednesday, 17 Apr 2019 

April 17 (Reuters) - Mediclinic International PLC ::2019 FULL YEAR TRADING UPDATE.GROUP RESULTS FOR 2019 FINANCIAL YEAR WERE IN LINE WITH MARKET EXPECTATIONS.IN SWITZERLAND, HIRSLANDEN'S PERFORMANCE IN SECOND HALF OF YEAR WAS AS GUIDED, RESULTING IN A FULL YEAR EBITDA MARGIN OF AROUND 16%.IN FINANCIAL YEAR ENDING 31 MARCH 2020 HIRSLANDEN EXPECTS MODEST REVENUE GROWTH FROM AN INCREASE IN AVERAGE BED CAPACITY FOR YEAR.IN CURRENT REGULATORY ENVIRONMENT, HIRSLANDEN TO BE IMPACTED BY FURTHER 9 MONTHS' EFFECT IN FY20 FROM NATIONAL OUTMIGRATION CARE PROGRAMME.HIRSLANDEN EBITDA MARGIN FOR FY19 WAS AROUND 16.0% (FY18: 18.3%).HIRSLANDEN FY20 EBITDA MARGIN EXPECTED TO BE AROUND 15%.IN FY20, MEDICLINIC SOUTHERN AFRICA EXPECTS VOLUME GROWTH OF AROUND 1%.IN MEDICLINIC MIDDLE EAST, FY19 REVENUE WAS UP AROUND 7.0% (FY18: AED3 050M).IN FY20, MIDDLE EAST DIVISION IS EXPECTED TO DELIVER REVENUE GROWTH OF AROUND 10%.AT GROUP LEVEL, IN CONSTANT CURRENCY, FY19 REVENUE WAS UP AROUND 3.5% AND EBITDA WAS DOWN AROUND 1.5%.ON A REPORTED BASIS, FY19 REVENUE WAS UP AROUND 2.0% (FY18: GBP2 870M) AND EBITDA WAS DOWN AROUND 3.5% (FY18: GBP515M).  Full Article

S.Africa's Competition Tribunal Stops Mediclinic Southern Africa- Matlosana Deal
Wednesday, 30 Jan 2019 

Jan 30 (Reuters) - S.AFRICA'S COMPETITION TRIBUNAL::PROHIBITED MERGER BETWEEN MEDICLINIC SOUTHERN AFRICA & MATLOSANA MEDICAL HEALTH SERVICES IN NORTH WEST PROVINCE.  Full Article

Mpilo Investment Holdings 2 (Rf) (Pty) Ltd Dissolves Stake In Mediclinic International Plc - Filing
Tuesday, 29 Jan 2019 

Jan 29 (Reuters) - Mediclinic International PLC ::MPILO INVESTMENT HOLDINGS 2 (RF) (PTY) LTD DISSOLVES STAKE IN MEDICLINIC INTERNATIONAL PLC - FILING.  Full Article

Mediclinic Says Forecast For Middle East Division Unchanged
Wednesday, 12 Dec 2018 

Dec 12 (Reuters) - Mediclinic International PLC ::GUIDANCE FOR MEDICLINIC MIDDLE EAST REMAINS UNCHANGED.MEDICLINIC MIDDLE EAST EXPECTS TO DELIVER FY19 REVENUE GROWTH IN HIGH SINGLE-DIGIT PERCENTAGE RANGE.  Full Article

Mediclinic Experiences Customary Seasonality In Switzerland, Middle East In H1 Trading
Wednesday, 17 Oct 2018 

Oct 17 (Reuters) - Mediclinic International PLC ::MEDICLINIC INTERNATIONAL - IN MIDDLE EAST, 182-BED MEDICLINIC PARKVIEW HOSPITAL IN DUBAI OPENED IN SEPTEMBER ON TIME AND IN BUDGET.MEDICLINIC INTERNATIONAL PLC - RECENTLY COMPLETED BUILD OF OUR FOURTH DAY CLINIC AT MEDICLINIC NEWCASTLE WHICH IS EXPECTED TO OPEN SHORTLY.MEDICLINIC INTERNATIONAL PLC - CONTINUE TO PROGRESS WITH HIRSLANDEN 2020 STRATEGIC PROGRAMME.MEDICLINIC INTERNATIONAL PLC - TRADING IN FIRST HALF OF YEAR EXPERIENCED CUSTOMARY SEASONALITY IN SWITZERLAND AND MIDDLE EAST.MEDICLINIC INTERNATIONAL PLC - IN MIDDLE EAST, WE DELIVERED A GRADUAL IMPROVEMENT IN REVENUE AND MARGIN EXPANSION IN H1.MEDICLINIC INTERNATIONAL PLC - IN SWITZERLAND, BUSINESS CONTINUES TO ADAPT TO RECENT REGULATORY CHANGES IN OUTPATIENT ENVIRONMENT IN H1.MEDICLINIC INTERNATIONAL PLC - IN SOUTHERN AFRICA, H1 MARGINS WERE MAINTAINED ON LOWER VOLUMES DUE TO WEAKNESS IN Q2.MEDICLINIC INTERNATIONAL PLC - FOR FULL YEAR, PERFORMANCE IN SOUTHERN AFRICA REMAINS IN LINE WITH GUIDANCE.MEDICLINIC INTERNATIONAL PLC - IN MIDDLE EAST, FULL YEAR EBITDA DELIVERY REMAINS ON TRACK WITH REVENUE GROWTH LOWER THAN PREVIOUSLY EXPECTED.MEDICLINIC INTERNATIONAL PLC - IN SWITZERLAND, WE NOW EXPECT TO DELIVER MODEST REVENUE GROWTH IN FULL YEAR.MEDICLINIC INTERNATIONAL PLC - AT GROUP LEVEL, IN CONSTANT CURRENCY, 1H19 REVENUE WAS UP 2% AND ADJUSTED EBITDA WAS DOWN AROUND 4%.  Full Article

Mediclinic International Says Guidance Remains Unchanged With Trading In Line With Expectations
Thursday, 28 Jun 2018 

June 28 (Reuters) - Mediclinic International PLC ::GUIDANCE REMAINS UNCHANGED WITH TRADING IN LINE WITH EXPECTATIONS.  Full Article

Mediclinic International Says CEO To Continue As A Non-Executive Director
Thursday, 24 May 2018 

May 24 (Reuters) - Mediclinic International PLC ::CHIEF EXECUTIVE OFFICER TO CONTINUE AS A NON-EXECUTIVE DIRECTOR.CHIEF EXECUTIVE OFFICER TO CONTINUE AS A NON-EXECUTIVE DIRECTOR.RONNIE VAN DER MERWE WILL SUCCEED MEINTJES AS CHIEF EXECUTIVE DIRECTOR ON 1 JUNE 2018.  Full Article

Mediclinic International appoints Carel Aron Van Der Merwe as CEO designate​
Monday, 27 Nov 2017 

Nov 27 (Reuters) - Mediclinic International Plc ::‍ANNOUNCES APPOINTMENT OF CAREL ARON VAN DER MERWE, CURRENTLY GROUP CHIEF CLINICAL OFFICER, AS CHIEF EXECUTIVE OFFICER DESIGNATE​.MERWE ‍TO SUCCEED DANIE MEINTJES AS CEO OF COMPANY ON A DATE TO BE MUTUALLY AGREED, BUT NOT LATER THAN 1 AUGUST 2018​.  Full Article

Mediclinic International says H1 2018 ‍underlying EPS down 12 pct to 11.3 pence​
Thursday, 16 Nov 2017 

Nov 16 (Reuters) - MEDICLINIC INTERNATIONAL PLC ::H1 2018 ‍UNDERLYING EARNINGS PER SHARE DOWN 12% TO 11.3 PENCE​.‍H1 REVENUE UP 10% TO GBP1 405M; FLAT IN CONSTANT CURRENCY TERMS​.‍H1 UNDERLYING EBITDA UP 5% TO GBP232M; DECREASED BY 5% IN CONSTANT CURRENCY TERMS​.‍INTERIM DIVIDEND MAINTAINED AT 3.20 PENCE PER SHARE​.SEES MODEST REVENUE GROWTH IN ‍HIRSLANDEN FOR H2​.‍FOR SOUTHERN AFRICA GROUP EXPECTS REVENUE GROWTH TO BE AROUND 4%​ IN H2.‍SEES MARGINAL IMPROVEMENT IN MIDDLE EAST REVENUES FOR FULL YEAR, GRADUAL IMPROVEMENT IN UNDERLYING EBITDA MARGINS OVER TIME,​.‍HAD A GOOD START TO SECOND HALF OF FINANCIAL YEAR, WITH CURRENT TRADING ACROSS ALL OPERATING DIVISIONS IN LINE WITH EXPECTATIONS​.‍GUIDANCE FOR ALL OPERATING DIVISIONS REMAINS UNCHANGED WITH CURRENT 2H18 TRADING IN LINE WITH MANAGEMENT​.  Full Article

UPDATE 1-Mediclinic core profit falls on Swiss regulatory changes

JOHANNESBURG, May 23 Mediclinic International Plc, reported a 4% fall in full-year core profit on Thursday, in line with market expectations, hit by regulatory changes for its Swiss business.